StreetAlpha.app
Home › Stocks › HTFL

Heartflow, Inc. (HTFL)

Healthcare
$47.07
▲ +0.45%
LAST CLOSE · NOV 17

Heartflow sells AI software that analyzes heart CT scans to help doctors diagnose coronary artery disease. It last closed at $47.07 on Nov 17, up 0.45% on the day. HTFL last reported earnings on Thu, Nov 12, 2026. The average 12-month price target from 6 analysts is $65.17 (+38.4% from the last close), with a high of $70.00 and a low of $55.00. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (5 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in HTFL, 50% of them bullish and 50% bearish.

AI Auto Pilots
Is HTFL in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$238.7M
+47.4% vs a year ago
Net income
−$79.0M
−33.1% margin
Free cash flow
−$56.1M
−23.5% margin
Gross margin
81.8%
$195.3M gross profit
Valuation
Market cap
$4.1B
87.9M shares
P/E
–
Price to sales
17.3
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$31.6M
At Sep 30
Shareholder equity
$282.5M
Shares outstanding
87.9M
At Oct 31
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2023: $87.2M$87.2MFY2023FY2024: $125.8M$125.8MFY2024FY2025: $176.0M$176.0MFY2025

From HTFL's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Last report
Nov 12
2026 · After the close (AMC)
Reported EPS
-$0.12
vs -$0.18 est. · beat
Year-ago EPS
—
Not on file
Options-implied move
±17.5%
Priced in before that report
Analyst consensus
Strong Buy
Based on 6 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
6firms
5 Buy1 Hold0 Sell
Each firm's latest rating on HTFL in the past 90 days
Average 12-month target
$65.17
▲ 38.4% upside

Based on 6 analysts who set a price target on HTFL in the past 90 days. The average target is $65.17, with a high of $70.00 and a low of $55.00, compared with the last close of $47.07.

Low $55.00Avg $65.17High $70.00
Blue marker: last close $47.07
Highest target$70.00
Average target$65.17
Lowest target$55.00
Latest rating changes
Freedom Capital MarketsTarget raised
Nov 17Buy$37 → $59
Wells FargoTarget raised
Nov 13Buy$39 → $70
Canaccord GenuityTarget raised
Nov 13Buy$56 → $69
StifelTarget raised
Nov 13Buy$45 → $70
BairdTarget raised
Nov 13Buy$34 → $68
DateFirmActionRatingPrice target
Nov 17Freedom Capital MarketsTarget raisedBuy$37 → $59
Nov 13Wells FargoTarget raisedBuy$39 → $70
Nov 13Canaccord GenuityTarget raisedBuy$56 → $69
Nov 13StifelTarget raisedBuy$45 → $70
Nov 13BairdTarget raisedBuy$34 → $68
Loading…

Technical Analysis

HTFL · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend, nearing oversold

The stock is 17% below its 20 day and 10% below its 50 day average. It is 25% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 40), near oversold. The nearest support is the Pivot at $46.97, and the nearest resistance the Pivot R1 at $48.15.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 7.9%/day
Key levels
$60.6652 week high+28.9%
$55.2620 day average+17.4%
$51.8650 day average+10.2%
$50.82Swing high (Sep 14)+8.0%
$48.15Pivot R1+2.3%
$47.07Last close
$46.97Pivot−0.2%
$46.78Swing low (Sep 23)−0.6%
$45.90Pivot S1−2.5%
$43.01100 day average−8.6%
$35.39200 day average−24.8%
$20.1352 week low−57.2%
Indicators
RSI (14)39.61Weak, oversold below 30Neutral
MACD-0.33Below its signal lineBearish
Stochastic4.3Near the bottom of its rangeOversold
ADX (14)20.4Weak trend
Williams %R-91.5Oversold below −80, overbought above −20Oversold
CCI (20)-221.3Oversold below −100, overbought above 100Oversold
Rate of change−13.5%Change over 10 sessionsBearish
ATR (14)$3.73Typical daily range, 7.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for HTFL

What happened before

See how HTFL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Whale Options Flow

90D
Total alerts
2
Bullish
1
50%
Bearish
1
50%
Date span
Oct 23 – Oct 28
Loading…

See today’s whale options flow across the market →

HTFL Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲164 buying vs 96 selling
  • ▼Held by funds -0.6 pts
  • ▲Funds holding +56
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding250194+28.9%
In funds' top 1052+150.0%
Held by funds84.6%85.3%−0.6 pts
New / increased84 / 8050 / 91+16.3%
Reduced / sold out67 / 2937 / 24+57.4%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See HTFL institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HTFL is in one of them and how their past HTFL trades turned out.

HTFL in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered HTFL in an article yet. Here's the latest on the wider market.

About Heartflow

Heartflow makes AI software that analyzes standard coronary CT angiography scans to help doctors diagnose and manage coronary artery disease, a leading cause of death. The software builds a personalized 3D model of a patient's heart from a single scan and reports on blood flow, narrowing and plaque. Its customers are hospitals and outpatient imaging centers, where cardiologists and radiologists use the tools in their routine workflows. The company is based in San Francisco, California.

Headquarters
San Francisco, CA